Drug Type Monoclonal antibody |
Synonyms |
Target |
Action antagonists |
Mechanism FGF19 antagonists(Fibroblast growth factor 19 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | China | 02 Aug 2022 | |
Colorectal Cancer | Phase 2 | China | 02 Aug 2022 | |
Hepatocellular Carcinoma | Phase 2 | China | 02 Aug 2022 | |
Stomach Cancer | Phase 2 | China | 02 Aug 2022 |